If cancer cells represent a kind of immortality (having lost their inability to die naturally), then it is not [MORE]
Breast Cancer Research
In 1955, the National Cancer Institute began organizing oncologists into regional study groups to address specific interests [MORE]
The theme of last year’s Medical Automation Conference was “patient discovery”-i.e. the idea that identifying molecular pathways in individuals’ [MORE]
Jonathan Sebat, PhD
A research group at the University of California San Diego has identified a genetic mutation linked to [MORE]
Lupus is a mysterious disease of unknown etiology, presenting symptoms of several disorders, especially during its early stages. Thus, [MORE]
For personalized molecular medicine to become a common practice, science need more information about the molecular phenomena of developmental [MORE]
The breakthroughs in molecular medicine open new vistas for health, but before this translates into healthcare, astute physicians must [MORE]
This past summer, life sciences instrument maker Illumina, Inc. (San Diego, CA) announced its founding of a collaboration [MORE]
RainDance Microfluidics
RainDance, Inc.is in a storied location to start a revolution: Lexington, MA. The company is developing picoliter droplet-based [MORE]
Micro RNA
Unlike messenger RNAs that encode protein formation, microRNAs bind to mRNA and assist in assembling proteins. Like degraded [MORE]
Cancerous tumors are made up of both normal and malignant cells, and at the root of their growth are [MORE]
Most of the R&D work on induced pluripotent stem cells has been done with skin tissue, but recently, investigators at [MORE]
In studies of twins at St. Thomas Hospital, London, King’s College researchers identified 163 biomarkers in blood that can indicate [MORE]
Nanoparticles entering a cell
Cancer researchers and physicians are awaiting clinical outcome data that Mark Davis and colleagues will present [MORE]